New Releases from NCBI BookshelfDaratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis.Daratumumab in combination for treating newly diagnosed systemic amyloid light-chain amyloidosis.
Post Content
Uncategorized
New Releases from NCBI BookshelfMultiple Symptoms Study 3 – An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled Trial [Internet].Multiple Symptoms Study 3 – An extended-role general practitioner clinic for patients with persistent physical symptoms: a Randomised Controlled Trial [Internet].
People with multiple and persistent physical symptoms have impaired quality of life and poor experiences of health care. We aimed
Uncategorized
New Releases from NCBI BookshelfAnti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis [Internet].Anti-VEGF drugs compared with laser photocoagulation for the treatment of proliferative diabetic retinopathy: a systematic review and individual participant data meta-analysis [Internet].
Proliferative diabetic retinopathy is a major cause of sight loss in people with diabetes, with a high risk of vitreous
Uncategorized
New Releases from NCBI BookshelfA personalised health intervention to maintain independence in older people with mild frailty: a process evaluation within the HomeHealth RCT [Internet].A personalised health intervention to maintain independence in older people with mild frailty: a process evaluation within the HomeHealth RCT [Internet].
Frailty is common in later life and can lead to adverse health outcomes. Services aimed at preventing decline in early
Uncategorized
New Releases from NCBI BookshelfBuilding Institutional Capacity for Engaged Research: Proceedings of a Workshop.Building Institutional Capacity for Engaged Research: Proceedings of a Workshop.
The complex challenges facing society today call for new ways of doing research that bring researchers, policy makers, community leaders
Uncategorized
New Releases from NCBI BookshelfTreosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal).Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal).
Post Content
